Live Webinar

Optimizing Commercial Pharma Channels During COVID-19

This webinar, part of our Analytics in 20 series, discusses using analytics to optimize sales channel activity and connect with prescribers in new ways.

June 24 • 1:30 p.m. ET • Cost: Complimentary

analytics in 20

About the webinar

This webinar will discuss the shifts in the way pharmaceutical companies need to reach prescribers due to the coronavirus pandemic and the role of engagement analytics in optimizing sales channel activity.

Many physicians are on the front lines of the crisis. Others are working more from home, using telemedicine technology whenever possible.

As a result of these shifts, pharmaceutical companies have an opportunity to connect with prescribing doctors in new ways.

To listen to the first part of this webinar, click here to add it to your calendar. No registration is required.

Why attend?

  • Make better decisions about your sales and marketing strategy during the crisis with engagement analytics.
  • Shift channels quickly to meet prescribers where they are.
  • Learn about providing digital content that adds value to your audiences’ experience, whether they be health care providers on the front line of the pandemic or those working from home.

Have a SAS profile? To complete this form automatically Sign In


All personal information will be handled in accordance with the SAS Privacy Statement.

  Yes, I would like to receive occasional emails from SAS Institute Inc. and its affiliates about SAS products and services. I understand that I can withdraw my consent at any time by clicking the opt-out link in the emails.

About the Experts

Speaker 2

Patrick Homer, Advisory Industry Consultant, SAS     

Homer is a thought leader in the field of transformational analytics across clinical and commercial pharma and has been involved with both the long-term strategy and development of SAS' solutions in these areas. His analytical expertise resides in predictive analytics, optimization, business intelligence, data management, forecasting, artificial intelligence and the development of analytical platforms. Since joining SAS in 2008, Homer has overseen the development of a portfolio of advanced analytical capabilities for life sciences. Most recently he led the development of an analytical platform for global price intelligence, revolutionizing the industry approach to global launch sequencing with next-generation optimization algorithms. Prior to working at SAS, Homer spent 20 years in the pharmaceutical industry, progressing through sales and management roles and on to executive business development for outsourced sales teams.

Speaker 2

Andy Bayliss, Principal Technical Account Manager, SAS

Bayliss works with many large pharmaceutical and life science companies. In his spare time, he is a keen cyclist and is constantly planning his next cycling adventure.

Back to Top